FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556167549> ?p ?o ?g. }

• W2556167549 endingPage "e0166725" @default.
• W2556167549 startingPage "e0166725" @default.
• W2556167549 abstract "Obstructive sleep apnoea (OSA) induces thrombophilia and reduces fibrinolysis. Alpha-2-antiplasmin (a-2-AP) and plasminogen activator inhibitor 1 (PAI-1) are major inhibitors of the fibrinolytic system. Increased concentrations of these factors are associated with a higher risk of cardiovascular diseases. The aim of this study was to assess plasma a-2-AP and PAI-1 in patients with OSA and evaluate correlations with the polysomnographic record and selected risk factors of cardiovascular diseases. The study group comprised 45 patients with OSA, and the control group consisted of 19 patients who did not meet the diagnostic criteria of OSA. Plasma a-2-AP and PAI-1 concentrations were assessed by enzyme-linked immunosorbent assay (ELISA). In the study group, the median value of plasma a-2-AP was higher than that of the control group (157.34 vs. 11.89 pg/ml, respectively, P<0.0001). A-2-AP concentration increased proportionally to the severity of OSA. The concentration of a-2-AP was positively correlated with the apnoea-hypopnoea index (AHI), apnoea index (AI), respiratory disturbances time (RDT), and desaturaion index (DI), and negatively correlated with mean and minimal oxygen saturation (SpO2 mean, SpO2 min, respectively). The median value of PAI-1 was higher in the study group than the control group (12.55 vs. 5.40 ng/ml, respectively, P = 0.006) and increased along with OSA severity. PAI-1 concentration was positively correlated with AHI, AI, RDT, DI, and body mass index (BMI) and negatively correlated with SpO2 mean and SpO2 min. Higher plasma concentrations of a-2-AP and PAI-1 in patients with OSA indicated that these patients had increased prothrombotic activity. OSA increases the risk of cardiovascular complications as it enhances prothrombotic activity." @default.
• W2556167549 created "2016-11-30" @default.
• W2556167549 creator A5002414785 @default.
• W2556167549 creator A5011542922 @default.
• W2556167549 creator A5014434582 @default.
• W2556167549 creator A5029850136 @default.
• W2556167549 creator A5035522985 @default.
• W2556167549 creator A5042076829 @default.
• W2556167549 creator A5051306630 @default.
• W2556167549 creator A5051377950 @default.
• W2556167549 creator A5072579730 @default.
• W2556167549 date "2016-11-18" @default.
• W2556167549 modified "2023-10-12" @default.
• W2556167549 title "Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea" @default.
• W2556167549 cites W10868135 @default.
• W2556167549 cites W113566499 @default.
• W2556167549 cites W1498296186 @default.
• W2556167549 cites W1964192238 @default.
• W2556167549 cites W1975662035 @default.
• W2556167549 cites W1987236559 @default.
• W2556167549 cites W2002624460 @default.
• W2556167549 cites W2009383527 @default.
• W2556167549 cites W2009948616 @default.
• W2556167549 cites W2017243328 @default.
• W2556167549 cites W2020001173 @default.
• W2556167549 cites W2024428648 @default.
• W2556167549 cites W2035199742 @default.
• W2556167549 cites W2050244432 @default.
• W2556167549 cites W2057543584 @default.
• W2556167549 cites W2058118966 @default.
• W2556167549 cites W2060091831 @default.
• W2556167549 cites W2061534229 @default.
• W2556167549 cites W2066441197 @default.
• W2556167549 cites W2068017066 @default.
• W2556167549 cites W2093960165 @default.
• W2556167549 cites W2106917137 @default.
• W2556167549 cites W2113283606 @default.
• W2556167549 cites W2115730526 @default.
• W2556167549 cites W2117075490 @default.
• W2556167549 cites W2124052130 @default.
• W2556167549 cites W2128343978 @default.
• W2556167549 cites W2151012450 @default.
• W2556167549 cites W2180160938 @default.
• W2556167549 cites W2287328722 @default.
• W2556167549 cites W2414870796 @default.
• W2556167549 cites W2443495543 @default.
• W2556167549 cites W2611131415 @default.
• W2556167549 cites W2785563066 @default.
• W2556167549 cites W83377979 @default.
• W2556167549 doi "https://doi.org/10.1371/journal.pone.0166725" @default.
• W2556167549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5115791" @default.
• W2556167549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27861608" @default.
• W2556167549 hasPublicationYear "2016" @default.
• W2556167549 type Work @default.
• W2556167549 sameAs 2556167549 @default.
• W2556167549 citedByCount "17" @default.
• W2556167549 countsByYear W25561675492017 @default.
• W2556167549 countsByYear W25561675492018 @default.
• W2556167549 countsByYear W25561675492019 @default.
• W2556167549 countsByYear W25561675492020 @default.
• W2556167549 countsByYear W25561675492021 @default.
• W2556167549 countsByYear W25561675492022 @default.
• W2556167549 countsByYear W25561675492023 @default.
• W2556167549 crossrefType "journal-article" @default.
• W2556167549 hasAuthorship W2556167549A5002414785 @default.
• W2556167549 hasAuthorship W2556167549A5011542922 @default.
• W2556167549 hasAuthorship W2556167549A5014434582 @default.
• W2556167549 hasAuthorship W2556167549A5029850136 @default.
• W2556167549 hasAuthorship W2556167549A5035522985 @default.
• W2556167549 hasAuthorship W2556167549A5042076829 @default.
• W2556167549 hasAuthorship W2556167549A5051306630 @default.
• W2556167549 hasAuthorship W2556167549A5051377950 @default.
• W2556167549 hasAuthorship W2556167549A5072579730 @default.
• W2556167549 hasBestOaLocation W25561675491 @default.
• W2556167549 hasConcept C126322002 @default.
• W2556167549 hasConcept C134018914 @default.
• W2556167549 hasConcept C2776572282 @default.
• W2556167549 hasConcept C2776825266 @default.
• W2556167549 hasConcept C2779679481 @default.
• W2556167549 hasConcept C2780221984 @default.
• W2556167549 hasConcept C2780675426 @default.
• W2556167549 hasConcept C71924100 @default.
• W2556167549 hasConcept C90924648 @default.
• W2556167549 hasConceptScore W2556167549C126322002 @default.
• W2556167549 hasConceptScore W2556167549C134018914 @default.
• W2556167549 hasConceptScore W2556167549C2776572282 @default.
• W2556167549 hasConceptScore W2556167549C2776825266 @default.
• W2556167549 hasConceptScore W2556167549C2779679481 @default.
• W2556167549 hasConceptScore W2556167549C2780221984 @default.
• W2556167549 hasConceptScore W2556167549C2780675426 @default.
• W2556167549 hasConceptScore W2556167549C71924100 @default.
• W2556167549 hasConceptScore W2556167549C90924648 @default.
• W2556167549 hasIssue "11" @default.
• W2556167549 hasLocation W25561675491 @default.
• W2556167549 hasLocation W25561675492 @default.
• W2556167549 hasLocation W25561675493 @default.
• W2556167549 hasLocation W25561675494 @default.
• W2556167549 hasLocation W25561675495 @default.

• next